Effects of stopping bisphosphonate treatment on height, weight, BMD and bone turnover in children with Osteogenesis Imperfecta (OI)

被引：0
|
作者：
DiMeglio, L. A. [1 ]
Ford, L. [1 ]
Peacock, M. [1 ]
机构：
[1] Indiana Univ, Indianapolis, IN 46204 USA
来源：
BONE | 2007年 / 40卷 / 06期
关键词：
D O I：
10.1016/j.bone.2007.04.036
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S39 / S39
页数：1
相关论文
共 50 条
  • [31] Changes in serum bone turnover markers and bone mineral density Z-score in children with osteogenesis imperfecta after zoledronic acid treatment
    Jin, Jiahui
    Yue, Luo
    Lu, Yili
    Zhen, Zhichao
    Wu, Huiping
    Shan, Xiaoou
    JOURNAL OF INVESTIGATIVE MEDICINE, 2024, 72 (07) : 715 - 722
  • [32] Biochemical bone markers in the assessment and pamidronate treatment of children and adolescents with osteogenesis imperfecta
    Astrom, E.
    Magnusson, P.
    Eksborg, S.
    Soderhall, S.
    ACTA PAEDIATRICA, 2010, 99 (12) : 1834 - 1840
  • [33] RESOLUTION OF EFFECTS ON BONE TURNOVER MARKERS AND BMD AFTER DISCONTINUATION OF LONG-TERM BISPHOSPHONATE USE
    De Villiers, Tobias
    Benhamou, Claude
    Johnston, C. Conrad
    Langdahl, Bente
    Saag, Kenneth
    Denker, Andrew
    Pong, Annpey
    Mcginnis, John, II
    Rosenberg, Elizabeth
    Santora, Arthur
    OSTEOPOROSIS INTERNATIONAL, 2013, 24 : S138 - S138
  • [34] Effects of pamidronate on bone modeling, bone remodeling and degree of mineralization of bone from children with osteogenesis imperfecta
    Boivin, G
    Chavassieux, P
    Forin, V
    Pinto, G
    Meunier, PJ
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (09) : S24 - S24
  • [35] Gain in BMD and grip strength after one year of pamidronate treatment in 132 children with osteogenesis imperfecta.
    Plotkin, H
    Montpetit, K
    Cloutier, S
    Bilodeau, N
    Gervais, N
    Rabzel, M
    Travers, R
    Glorieux, FH
    JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 : S484 - S484
  • [36] Effects of different bisphosphonates on bone metabolism in children with osteogenesis imperfecta. pre study
    Papassotiriou, I.
    Matsinos, G.
    Douskas, G.
    Prountzou-Kassiou, K.
    BONE, 2007, 40 (06) : S308 - S309
  • [37] The Long-Term Effects of Switching from Active Intravenous Bisphosphonate Treatment to Low-Dose Maintenance Therapy in Children with Osteogenesis Imperfecta
    Biggin, Andrew
    Zheng, Linda
    Briody, Julie N.
    Coorey, Craig P.
    Munns, Craig F.
    HORMONE RESEARCH IN PAEDIATRICS, 2015, 83 (03): : 183 - 189
  • [38] COMPUTED-TOMOGRAPHY (CT) BONE-DENSITY IN CHILDREN WITH OSTEOGENESIS IMPERFECTA (OI), INFANTS WITH MULTIPLE UNEXPLAINED FRACTURES (MUF), AND CONTROLS
    MILLER, ME
    HANGARTNER, TN
    PEDIATRIC RESEARCH, 1995, 37 (04) : A150 - A150
  • [39] Early treatment with intravenous bisphosphonates prevents severe postnatal bone loss in children with Osteogenesis imperfecta
    Rehberg, Mirko
    Heistermann, Johanna
    Schoenau, Eckhard
    Semler, Joerg
    Hoyer-Kuhn, Heike
    HORMONE RESEARCH IN PAEDIATRICS, 2019, 91 : 125 - 126
  • [40] Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta
    Horwitz, EM
    Prockop, DJ
    Fitzpatrick, LA
    Koo, WWK
    Gordon, PL
    Neel, M
    Sussman, M
    Orchard, P
    Marx, JC
    Pyeritz, RE
    Brenner, MK
    NATURE MEDICINE, 1999, 5 (03) : 309 - 313
12345